Last 48 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 59.97 | 46.20 | 20.34 | 23.60 | 1448.68 | 15.81 | 23.03 | 16.59 | 30.44 | 44.53 | 37.33 | 27.22 | 31.25 | 44.68 | 37.87 | 34.20 | 23.68 | 38.42 | 44.71 | 84.16 | — |
| — | +192.2% | -11.7% | +42.3% | +4659.8% | -64.5% | -38.3% | -39.0% | -2.6% | -0.3% | -1.4% | -20.4% | +32.0% | +16.3% | -15.3% | -59.4% | — | +2.6% | +65.8% | +228.0% | — | |
| P/S Ratio | 1.61 | 1.63 | 1.05 | 1.70 | 1.67 | 1.43 | 1.80 | 2.11 | 2.95 | 3.08 | 3.34 | 2.85 | 2.49 | 2.56 | 2.23 | 2.04 | 1.95 | 2.30 | 2.64 | 3.40 | 2.83 |
| — | +13.6% | -41.5% | -19.4% | -43.4% | -53.5% | -46.3% | -25.8% | +18.8% | +20.4% | +50.0% | +39.5% | +27.4% | +11.0% | -15.6% | -40.0% | -31.2% | -27.2% | -13.4% | -0.4% | -21.7% | |
| P/B Ratio | 1.49 | 1.43 | 0.92 | 1.57 | 1.46 | 1.21 | 1.51 | 1.81 | 2.45 | 2.73 | 2.96 | 2.55 | 2.28 | 2.35 | 2.04 | 1.88 | 1.84 | 2.19 | 2.49 | 3.18 | 2.66 |
| — | +18.4% | -39.3% | -13.6% | -40.3% | -55.6% | -48.9% | -28.9% | +7.6% | +16.0% | +45.4% | +35.1% | +23.9% | +7.3% | -18.1% | -40.7% | -30.7% | -59.8% | -54.0% | -43.4% | -55.3% | |
| P/FCF | 15.45 | 14.28 | 15.69 | 5.78 | 9.71 | 22.68 | 15.03 | 15.56 | 16.68 | 35.84 | 23.31 | 15.18 | 16.35 | 30.09 | 29.65 | — | 21.48 | 28.99 | 24.23 | 26.48 | 19.27 |
| — | -37.0% | +4.4% | -62.9% | -41.8% | -36.7% | -35.5% | +2.5% | +2.0% | +19.1% | -21.4% | — | -23.9% | +3.8% | +22.4% | — | +11.5% | +21.3% | -4.4% | +75.8% | -20.3% | |
| EV / EBITDA | 11.63 | 13.62 | 10.69 | 8.69 | 11.73 | 12.00 | 13.80 | 12.90 | 17.74 | 19.24 | 17.95 | 16.01 | 14.43 | 16.93 | 14.73 | 14.45 | 12.66 | 17.41 | 19.91 | 25.54 | 40.47 |
| — | +13.5% | -22.6% | -32.6% | -33.9% | -37.7% | -23.1% | -19.5% | +23.0% | +13.6% | +21.9% | +10.8% | +14.0% | -2.8% | -26.0% | -43.4% | -68.7% | -8.0% | +12.8% | +40.2% | +105.3% | |
| EV / EBIT | 16.02 | 20.60 | 15.10 | 21.63 | 47.45 | 17.43 | 19.68 | 18.88 | 23.32 | 31.60 | 27.15 | 25.33 | 22.86 | 29.52 | 25.23 | 25.19 | 18.93 | 26.79 | 33.26 | 52.81 | 1272.72 |
| — | +18.2% | -23.3% | +14.6% | +103.4% | -44.8% | -27.5% | -25.5% | +2.0% | +7.1% | +7.6% | +0.6% | +20.8% | +10.2% | -24.1% | -52.3% | -98.5% | +16.8% | +55.8% | +154.0% | +5505.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.4% | 18.8% | 23.5% | 22.8% | 22.3% | 27.8% | 27.9% | 29.4% | 29.1% | 29.6% | 29.6% | 30.0% | 29.5% | 29.2% | 29.5% | 29.6% | 29.2% | 28.1% | 27.5% | 28.0% | 27.2% |
| — | -32.4% | -15.8% | -22.5% | -23.4% | -5.8% | -5.7% | -2.2% | -1.2% | +1.1% | +0.5% | +1.4% | +1.1% | +4.2% | +7.1% | +5.8% | +7.1% | +1.9% | +1.8% | -5.3% | -8.2% | |
| Operating Margin | 12.3% | 9.4% | 8.5% | 10.0% | 12.7% | 10.4% | 11.0% | 14.6% | 14.1% | 10.8% | 13.7% | 12.9% | 12.9% | 10.4% | 11.0% | 10.4% | 12.5% | 9.2% | 9.0% | 7.7% | 0.3% |
| — | -9.2% | -22.1% | -31.4% | -9.9% | -4.3% | -19.7% | +13.2% | +9.3% | +4.6% | +24.6% | +24.0% | +2.5% | +12.9% | +22.3% | +35.2% | +4484.7% | -29.1% | -33.7% | -51.4% | -98.2% | |
| Net Margin | 2.8% | 3.5% | 5.1% | 7.1% | 0.1% | 9.1% | 7.7% | 12.7% | 9.7% | 6.9% | 9.0% | 10.5% | 8.0% | 5.7% | 5.9% | 6.0% | 8.2% | 6.0% | 5.9% | 4.1% | -5.1% |
| — | -61.2% | -33.1% | -44.6% | -98.8% | +30.9% | -14.1% | +21.6% | +21.9% | +21.1% | +52.1% | +75.0% | -3.4% | -4.3% | +0.1% | +47.6% | +263.2% | -29.5% | -48.0% | -69.5% | -138.7% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.5% | 0.8% | 1.1% | 1.6% | 0.0% | 1.9% | 1.6% | 2.7% | 2.0% | 1.5% | 2.0% | 2.4% | 1.8% | 1.3% | 1.4% | 1.4% | 2.0% | 1.4% | 1.4% | 1.0% | -1.9% |
| — | -59.5% | -30.1% | -40.2% | -98.8% | +24.3% | -19.3% | +13.3% | +10.5% | +16.6% | +47.6% | +69.5% | -5.7% | -7.2% | -2.0% | +47.2% | +203.6% | -61.7% | -73.0% | -83.2% | -133.9% | |
| ROA | 1.4% | 0.4% | 0.6% | 0.9% | 0.0% | 1.1% | 0.9% | 1.5% | 1.2% | 0.9% | 1.1% | 1.3% | 1.0% | 0.7% | 0.7% | 0.7% | 0.9% | 0.7% | 0.6% | 0.4% | -0.9% |
| — | -59.6% | -29.9% | -40.3% | -98.8% | +27.1% | -16.7% | +19.9% | +20.3% | +28.5% | +62.7% | +85.8% | +2.3% | -0.7% | +4.4% | +56.9% | +205.6% | -67.7% | -77.0% | -86.0% | -128.7% | |
| ROIC | 6.2% | 1.2% | 1.1% | 1.3% | 1.5% | 1.2% | 1.3% | 1.8% | 1.7% | 1.4% | 1.7% | 1.6% | 1.5% | 1.2% | 1.2% | 1.2% | 1.4% | 1.0% | 1.0% | 0.8% | 0.1% |
| — | -2.3% | -17.7% | -27.0% | -8.7% | -8.6% | -22.0% | +13.5% | +9.9% | +12.4% | +34.5% | +30.8% | +6.6% | +15.9% | +26.0% | +42.9% | +2623.4% | -83.0% | -83.8% | -86.8% | -99.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.37 | 0.38 | 0.39 | 0.38 | 0.37 | 0.37 | 0.38 | 0.37 | 0.37 | 0.39 | 0.43 | 0.46 | 0.50 | 0.53 | 0.57 | 0.60 | 0.64 | 0.66 | 0.70 | 0.77 |
| — | +0.3% | +0.7% | +2.2% | +4.5% | -0.7% | -3.1% | -11.2% | -21.2% | -26.0% | -27.6% | -25.0% | -23.1% | -20.8% | -18.6% | -18.8% | -21.3% | +225.4% | +216.8% | +198.6% | +218.6% | |
| Debt / EBITDA | 2.55 | 11.89 | 13.28 | 7.14 | 9.99 | 11.56 | 11.28 | 9.15 | 9.45 | 9.44 | 8.39 | 9.31 | 9.90 | 12.11 | 12.38 | 13.58 | 12.91 | 16.14 | 16.99 | 18.89 | 37.70 |
| — | +2.9% | +17.8% | -22.0% | +5.7% | +22.4% | +34.5% | -1.7% | -4.5% | -22.0% | -32.3% | -31.4% | -23.3% | -25.0% | -27.1% | -28.1% | -65.8% | +456.7% | +495.8% | +496.7% | +1044.4% | |
| Current Ratio | 1.10 | 0.95 | 1.14 | 1.10 | 1.06 | 1.29 | 1.27 | 1.26 | 1.34 | 1.31 | 1.21 | 1.21 | 1.19 | 1.22 | 1.18 | 1.20 | 1.16 | 1.18 | 1.13 | 1.19 | 1.36 |
| — | -26.4% | -10.4% | -13.2% | -21.0% | -1.5% | +5.3% | +4.6% | +12.5% | +7.7% | +2.0% | +0.6% | +2.6% | +3.3% | +4.7% | +1.2% | -14.6% | -42.9% | -43.8% | -36.6% | -4.5% | |
| Quick Ratio | 1.10 | 0.95 | 1.14 | 1.10 | 1.06 | 1.29 | 1.27 | 1.26 | 1.34 | 1.31 | 1.21 | 1.21 | 1.19 | 1.22 | 1.18 | 1.20 | 1.16 | 1.18 | 1.13 | 1.19 | 1.36 |
| — | -26.4% | -10.4% | -13.2% | -21.0% | -1.5% | +5.2% | +4.6% | +12.5% | +7.7% | +2.1% | +0.8% | +2.6% | +3.3% | +4.7% | +0.9% | -14.6% | -42.9% | -43.8% | -36.6% | -4.5% | |
| Interest Coverage | 2.34 | 3.98 | 3.90 | 4.99 | 1.76 | 4.21 | 4.65 | 5.23 | 5.40 | 3.80 | 4.01 | 3.30 | 3.17 | 2.47 | 2.52 | 2.71 | 4.09 | 4.44 | 4.20 | 2.74 | 0.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ICLR stock.
ICON Public Limited Company's current P/E is 60.0x. The average P/E over the last 4 quarters is 384.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
ICON Public Limited Company's current operating margin is 12.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking ICON Public Limited Company's business trajectory between earnings reports.